Clinical trials
Terminated Phase 1 Neuroblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Novartis Pharmaceuticals | 2 |
| Actuate Therapeutics Inc. | 1 |
| AeRang Kim | 1 |
| Columbia University | 1 |
| Dana-Farber Cancer Institute | 1 |
| Giselle Sholler | 1 |
| GlaxoSmithKline | 1 |
| M.D. Anderson Cancer Center | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroblastoma | 24 |
| Neoplasms | 8 |
| Osteosarcoma | 6 |
| Rhabdomyosarcoma | 5 |
| Sarcoma | 5 |
| Central Nervous System Neoplasms | 3 |
| Medulloblastoma | 3 |
| Neuroectodermal Tumors, Primitive, Peripheral | 3 |
| Sarcoma, Ewing | 3 |
| Wilms Tumor | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.